Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €1.35 EUR
Change Today -0.013 / -0.95%
Volume 0.0
TO7 On Other Exchanges
Symbol
Exchange
TO7 is not on other exchanges.
As of 2:20 AM 04/30/15 All times are local (Market data is delayed by at least 15 minutes).

toyobo co ltd (TO7) Snapshot

Open
€1.35
Previous Close
€1.37
Day High
€1.36
Day Low
€1.35
52 Week High
04/14/15 - €1.42
52 Week Low
10/28/14 - €1.03
Market Cap
1.2B
Average Volume 10 Days
20.0
EPS TTM
--
Shares Outstanding
890.5M
EX-Date
03/27/15
P/E TM
--
Dividend
€3.62
Dividend Yield
1.99%
Current Stock Chart for TOYOBO CO LTD (TO7)

Related News

No related news articles were found.

toyobo co ltd (TO7) Related Businessweek News

No Related Businessweek News Found

toyobo co ltd (TO7) Details

Toyobo Co., Ltd. provides films and functional polymers, industrial materials, life science products, and textile products in Japan and internationally. The company’s Films and Functional Polymers segment offers industrial films, including PET films for use in liquid crystal displays, FPD, photovoltaic backsheets, touch screens, ceramic capacitor process sheets, and other industrial uses; and synthetic paper. This segment also provides packaging films, such as PET, polyolefin, and polyamide for food packaging, as well as shrinkable films for labels; and functional polymers comprising engineering plastics and acrylate polymers, as well as co-polyester and modified polyolefin for industrial adhesives and coatings. Its Industrial Materials segment provides functional fibers, such as airbag fabrics and polyester yarn; polyethylene fibers and PBO fibers; functional filters for use in automotive components, office equipment, and air purifiers; and volatile organic compound emissions treatment equipment and systems, as well as non-woven fabrics for automotive parts and construction materials. The company’s Life Science segment offers bio products comprising enzymes for diagnostics, diagnostic systems and reagents, research reagents, and cosmetic ingredients; medical membranes, equipment, and devices; reverse osmosis membranes for seawater desalination; and ultra-filtration membranes for drinking water. This segment is also involved in the contract manufacture of injections, raw pharmaceuticals, and antibody drugs. Its Textiles segment provides functional textiles for sports clothing, underwear, and uniforms; manufactures apparel under the MUNSINGWEAR brand; offers fibers for clothes; and provides acrylic fibers under the Exlan brand, as well as trades in clothes. The company also engages in real estate, engineering, information processing services, and logistics services businesses. Toyobo Co., Ltd. was founded in 1882 and is headquartered in Osaka, Japan.

10,487 Employees
Last Reported Date: 06/27/14
Founded in 1882

toyobo co ltd (TO7) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

toyobo co ltd (TO7) Key Developments

Toyobo Co., Ltd. Announces Consolidated Earnings Results for the Nine Months Ended December 31, 2014; Revises Earnings Guidance for the Year Ending March 31, 2015; Provides Yearend Dividend Guidance for the Year Ending March 31, 2015

Toyobo Co., Ltd. announced consolidated earnings results for the nine months ended December 31, 2014. For the nine months, the company reported net income of ¥5,870 million or ¥6.61 per share, ordinary income of ¥8,471 million, operating income of ¥12,524 million and net sales of ¥255,419 million compared to net income of ¥6,451 million or ¥7.26 per share, ordinary income of ¥14,360 million, operating income of ¥15,327 million and net sales of ¥257,478 million for the same period a year ago. Income before income taxes and minority interests was ¥7,603 million compared to ¥10,770 million for the same period a year ago. The company revised earnings guidance for the year ending March 31, 2015 as it develops the markets for new products and commences operations at new facilities, expenses are being incurred temporarily preceding the anticipated growth in sales. For the period, the company expected net income of ¥8,000 million or ¥9.01 per share, ordinary income of ¥15,500 million, operating income of ¥21,000 million and net sales of ¥360,000 million compared to previously expected net income of ¥8,500 million, ordinary income of ¥16,500 million, operating income of ¥22,000 million and net sales of ¥360,000 million. The company also provided yearend dividend guidance for the year ending March 31, 2015. For the period, the company expected a dividend of ¥3.50 per share.

Toyobo Co., Ltd. to Report Q3, 2015 Results on Feb 09, 2015

Toyobo Co., Ltd. announced that they will report Q3, 2015 results on Feb 09, 2015

Toyobo Co., Ltd., H1 2015 Earnings Call, Nov 05, 2014

Toyobo Co., Ltd., H1 2015 Earnings Call, Nov 05, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TO7:GR €1.35 EUR -0.013

TO7 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Baxter International Inc $69.43 USD +0.69
Fresenius Medical Care AG & Co KGaA €74.78 EUR -0.77
Polypore International Inc $58.70 USD +0.14
View Industry Companies
 

Industry Analysis

TO7

Industry Average

Valuation TO7 Industry Range
Price/Earnings 20.7x
Price/Sales 0.4x
Price/Book 1.1x
Price/Cash Flow 20.7x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TOYOBO CO LTD, please visit www.toyobo-global.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.